This paragraph focuses on the recent advances of aptasensors for cancer biomarker detection and monitoring, such as mucin 1, human epidermal growth factor receptor 2, prostate-specific antigen, carcinoembryonic antigen, vascular endothelial growth factor, and platelet-derived growth factors. Here, ERBB2 is linked to cancer.